Positron (OTCMKTS:POSC) and Electromed (NYSE:ELMD) Head to Head Review

Positron (OTCMKTS:POSCGet Rating) and Electromed (NYSE:ELMDGet Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.


This table compares Positron and Electromed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Positron N/A N/A N/A
Electromed 4.60% 5.73% 4.90%

Institutional and Insider Ownership

32.0% of Electromed shares are owned by institutional investors. 17.2% of Positron shares are owned by insiders. Comparatively, 12.3% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Positron and Electromed’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Positron N/A N/A N/A N/A N/A
Electromed $41.66 million 2.26 $2.31 million $0.22 50.46

Electromed has higher revenue and earnings than Positron.

Volatility & Risk

Positron has a beta of -0.81, suggesting that its share price is 181% less volatile than the S&P 500. Comparatively, Electromed has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Positron and Electromed, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Positron 0 0 0 0 N/A
Electromed 0 0 2 0 3.00

Electromed has a consensus price target of $16.75, indicating a potential upside of 50.90%. Given Electromed’s higher possible upside, analysts plainly believe Electromed is more favorable than Positron.


Electromed beats Positron on 8 of the 9 factors compared between the two stocks.

About Positron

(Get Rating)

Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. It operates through the Medical Equipment and Radiopharmaceuticals segments. It offers economical, end-to-end solutions for Positron Emission Tomography (PET) myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals, and radioisotopes. The company was founded by Roman Oliynyk on December 20, 1983 and is headquartered in Niagara Falls, NY.

About Electromed

(Get Rating)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Receive News & Ratings for Positron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Positron and related companies with MarketBeat.com's FREE daily email newsletter.